Erin Beattie

Network manager Erin Beattie

Network Manager

Neuromuscular Disease Network for Canada (NMD4C)

CHEO Research Institute


Email Erin

Biography

Erin Beattie is the Network Manager for the Neuromuscular Disease Network for Canada (NMD4C), where she leads the coordination of all network activities, fostering collaboration across clinical, research, and advocacy communities. With a deep commitment to strengthening neuromuscular and rare disease capacity in Canada, Erin plays a pivotal role in connecting stakeholders, supporting strategic initiatives, and advancing national programming. She holds a PhD in Laboratory Medicine & Pathobiology from the University of Toronto and an MSc in Pharmacology from Dalhousie University, with research focused on cardiac remodeling in heart failure. Prior to joining NMD4C, she worked as a Research & Development Scientist and Medical Writer at a clinical research organization specializing in respiratory trials, served as a Clinical Science Consultant, and coordinated research at the IBD Centre at the Children’s Hospital of Eastern Ontario (CHEO). Erin is dedicated to building sustainable networks and strengthening Canada’s neuromuscular and rare disease research landscape.


Recent Publications

Jones, J. Mediation learning module: Pedersen et al (2025), Associations of early life body size and pubertal timing with breast density and postmenopausal breast cancer risk: A mediation analysis. Ann Epidemiol. 2026.113 86-88 PMID:41513312

Ridgway, GR, Nakajima, T, Torso, M, Hardingham, I, Khosropanah, P, Ohta, K et al.. Biomarkers. Alzheimers Dement. 2025.21 Suppl 2 e107518 PMID:41511802

Boitsios, G, Saliba, T, Simoni, P. Comparative study of the performance of two versions of the same AI tool for pediatric skeletal maturation assessment. Eur Radiol. 2026. PMID:41498826

Liu, H, Zhang, J, Li, L, Yu, B, Zhang, C, Niu, W et al.. Corrigendum to "miR-9-5p alleviates the development of abdominal aortic aneurysm by regulating the differentiation of CD4+IL-10+T cells via targeting the crosstalk between Nrf2 and NF-κB signaling pathways" [Turkish Journal of Biology 49 (4) 2025 380-391]. Turk J Biol. 2025.49 (7)835-836 PMID:41496850

Kim, DH, Kim, D, Moon, JW, Chae, SW, Rhyu, IJ. Erratum: Correction of Text in the Article "Complications of Nasopharyngeal Swabs and Safe Procedures for COVID-19 Testing Based on Anatomical Knowledge". J Korean Med Sci. 2026.41 (1)e52 PMID:41492838

Nair K, Umapathy K, Farid T, Masse S, Mueller E, Sivanandan RV, Poku K, Rao V, Nair V, Butany J, Ideker RE, Nanthakumar K.Intramural activation during early human ventricular fibrillation. Circ Arrhythm Electrophysiol, 4(5): 692-703, 2011.

Mueller EE, Momen A, Massé S, Zhou YQ, Liu J, Backx PH, Henkelman RM, Nanthakumar K, Stewart DJ, Husain M.Electrical remodelling precedes heart failure in an endothelin-1 induced model of cardiomyopathy. Cardiovasc Res, 89(3): 623-33, 2011.

Mueller EE, Grandy SA, Ferrier GR, Howlett SE.PKA-mediated phosphorylation contributes to enhanced contraction observed in mice that over-express β-adrenergic receptor kinase--1. J Pharmacol Exp Ther, Dec; 319(3): 1307-16, 2006.

Grandy SA, Mueller EE, Ferrier GR, Howlett SE.The role of β-adrenergic receptor signaling in regulation of cardiac contraction. Recent Res Dev Physiol, 2: 1-19, 2004.

See more on PubMed